Tonix is enrolling participants in a Phase 3 trial for fibromyalgia, the RESILIENT study. For more information, please visit www.resilientstudy.com or www.clinicaltrials.gov (NCT05273749).
IR Events
B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
